Frexalimab
Frexalimab is an experimental drug that is currently being studied for its potential use in the treatment of various autoimmune diseases. It is a monoclonal antibody that targets the interleukin-6 receptor (IL-6R), a protein that plays a key role in the immune response.
Mechanism of action[edit]
Frexalimab works by binding to the IL-6R, thereby blocking the interaction between IL-6 and its receptor. This prevents the activation of the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway, which is involved in the production of inflammatory cytokines.
Clinical trials[edit]
Several clinical trials have been conducted to evaluate the safety and efficacy of frexalimab in patients with autoimmune diseases. These trials have shown promising results, with patients experiencing a reduction in disease activity and an improvement in quality of life.
Potential applications[edit]
Frexalimab is being investigated for its potential use in the treatment of a variety of autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, and Crohn's disease. It may also have potential applications in the treatment of other inflammatory conditions, such as psoriasis and asthma.
See also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
